Lasa Supergenerics Corporate Filings & Announcements

Latest corporate announcements and filings from Lasa Supergenerics on BSE

Load latest

Lasa Supergenerics Ltd.

22 Sep 2025

9.61

2.02%

Company Update

Lasa Supergenerics Ltd - 540702 - Annoucement Under Reg 30 Updates - Revised Disclosure Resignation Of …

BSE India

With the reference to the earlier disclosure submitted dated 29th August , 2025. We hereby submitting the revised Disclosure

pdf

Lasa Supergenerics Ltd.

05 Sep 2025

9.61

2.02%

Corp. Note

Lasa Supergenerics Ltd - 540702 - Reg. 34 (1) Annual Report.

BSE India

Annual Report for the financial year ended March 31, 2025 along with Notice of the Tenth (10th ) Annual General Meeting and Cut-off Date for the purpose of E voting

pdf

Lasa Supergenerics Ltd.

05 Sep 2025

9.61

2.02%

Corp. Note

Lasa Supergenerics Ltd - 540702 - Board Meeting Outcome for Outcome Of Board Meeting Held Today …

BSE India

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we would like to inform you that the Board of Directors at their meeting held today which commenced at 07.00 pm and concluded at 8.00 pm have considered and approved the following:

pdf

Lasa Supergenerics Ltd.

03 Sep 2025

9.61

2.02%

AGM

Lasa Supergenerics Ltd - 540702 - Shareholder Meeting / Postal Ballot-Scrutinizer"s Report

BSE India

We wish to informed you members of the Company has approved by way of postal ballot the resolution as set out in the Notice of Postal Ballot dated : 01.08.2025 with requisite majority

pdf

Lasa Supergenerics Ltd.

03 Sep 2025

9.61

2.02%

AGM

Lasa Supergenerics Ltd - 540702 - Shareholder Meeting / Postal Ballot-Outcome of Postal Ballot

BSE India

We wish to inform you that the members of the Company has approved by the way of postal ballot , the resolution under Companies Act 2013 and SEBI Listing Regulations as set out in the Notice Postal Ballot dated 01.08.2025 with the requisite majority

pdf

Lasa Supergenerics Ltd.

29 Aug 2025

9.61

2.02%

Company Update

Lasa Supergenerics Ltd - 540702 - Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance …

BSE India

With the reference to the Reg 30 of SEBI LODR resgulations, 2015 , we here inform you that Mrs Mitti Jain, Company Secretary and Compliance Officer of the Company has tendered her resignation w.e.f 29th August , 2025

pdf

Lasa Supergenerics Ltd.

13 Aug 2025

9.61

2.02%

Company Update

Lasa Supergenerics Ltd - 540702 - Integrated Filing June 2025

BSE India

Integrated filing June 2025

pdf

Lasa Supergenerics Ltd.

13 Aug 2025

9.61

2.02%

Result

Lasa Supergenerics Ltd - 540702 - Financial Results As On June 30, 2025

BSE India

Financials results as on June 30, 2025

pdf

Lasa Supergenerics Ltd.

13 Aug 2025

9.61

2.02%

Board Meeting

Lasa Supergenerics Ltd - 540702 - Board Meeting Outcome for Outcome Of Board Meeting Held Today …

BSE India

Pursuant to Regulation 29 and 30 of SEBI (Listing obligation and disclosure requirements) Regulations, 2015, we would like to inform you that the Board of Directors in their meeting held today which was commenced at 2.00 P.M. and concluded at 05.00 P.M. inter- alia have considered and approved the following: 1. The Unaudited Financial Results of the Company for the quarter ended June 30, 2025. 2. Limited Review Report from Statutory Auditor for the quarter ended on June 30, 2025.

pdf

Lasa Supergenerics Ltd.

05 Aug 2025

9.61

2.02%

Board Meeting

Lasa Supergenerics Ltd - 540702 - Board Meeting Intimation for The Quarter Ended June 30, 2025

BSE India

Lasa Supergenerics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2025 ,inter alia, to consider and approve Pursuant to Regulation 29 of the Securities and Exchange Board of the India (Listing Obligation and Disclosure Requirement) Regulation, 2015 notice is hereby given that Meeting of the Board of Directors of the Company is scheduled to be held on Wednesday, August 13, 2025, inter alia; 1. To consider, approve and take on records Unaudited financial results of the Company for the quarter ended June 30, 2025. 2. To discuss any other matter with the permission of the Chairperson. In accordance with the provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015 and Company's Code of Conduct, the Trading Window shall continue to remain closed till 48 hours after the declaration of the unaudited financial results of the Company for the quarter ended June 30, 2025.

pdf

Is Lasa Supergenerics Ltd. worth buying?

54 Votes:

Buy 77.78%

Sell 16.67%

Hold 5.56%